Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 5
2006 5
2007 2
2008 7
2009 3
2010 5
2011 2
2012 1
2013 3
2014 5
2015 9
2016 3
2017 3
2018 4
2019 3
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Temozolomide and unusual indications: review of literature.
Tatar Z, Thivat E, Planchat E, Gimbergues P, Gadea E, Abrial C, Durando X. Tatar Z, et al. Among authors: abrial c. Cancer Treat Rev. 2013 Apr;39(2):125-35. doi: 10.1016/j.ctrv.2012.06.002. Epub 2012 Jul 19. Cancer Treat Rev. 2013. PMID: 22818211 Review.
PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.
Lusho S, Durando X, Bidet Y, Molnar I, Kossai M, Bernadach M, Lacrampe N, Veyssiere H, Cavaille M, Gay-Bellile M, Radosevic-Robin N, Abrial C. Lusho S, et al. Among authors: abrial c. Medicine (Baltimore). 2020 Dec 11;99(50):e23418. doi: 10.1097/MD.0000000000023418. Medicine (Baltimore). 2020. PMID: 33327268 Free PMC article.
[Taste receptors in the lungs: interesting or anecdotal?].
Grassin-Delyle S, Abrial C, Brollo M, Naline E, Devillier P. Grassin-Delyle S, et al. Among authors: abrial c. Rev Pneumol Clin. 2014 Jun;70(3):148-55. doi: 10.1016/j.pneumo.2013.11.008. Epub 2014 Mar 16. Rev Pneumol Clin. 2014. PMID: 24646786 Review. French.
Neoadjuvant endocrine therapy in breast cancer.
Abrial C, Mouret-Reynier MA, Curé H, Feillel V, Leheurteur M, Lemery S, Le Bouëdec G, Durando X, Dauplat J, Chollet P. Abrial C, et al. Breast. 2006 Feb;15(1):9-19. doi: 10.1016/j.breast.2005.07.009. Epub 2005 Oct 17. Breast. 2006. PMID: 16230013 Review.
[Therapeutic potential of melatonin in cancer treatment].
Abrial C, Kwiatkowski F, Chevrier R, Gachon F, Curé H, Chollet P. Abrial C, et al. Pathol Biol (Paris). 2005 Jun;53(5):265-8. doi: 10.1016/j.patbio.2004.12.009. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939135 Review. French.
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier MA, Benmammar KE, Kullab S, Bahadoor M, Chollet P, Penault-Llorca F, Nabholtz JM. Wang-Lopez Q, et al. Among authors: abrial c. Crit Rev Oncol Hematol. 2015 Jul;95(1):88-104. doi: 10.1016/j.critrevonc.2015.02.011. Epub 2015 Mar 4. Crit Rev Oncol Hematol. 2015. PMID: 25900915 Review.
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page